Astellas Pharma Inc.
ALPMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $188,372,000 | $335,687,000 | $376,840,000 | $315,986,000 |
| Short-Term Investments | $29,941,000 | $28,784,000 | $19,784,000 | $21,297,000 |
| Receivables | $632,525,000 | $534,985,000 | $427,965,000 | $382,462,000 |
| Inventory | $297,261,000 | $248,738,000 | $174,386,000 | $153,072,000 |
| Other Curr. Assets | $53,250,000 | $46,536,000 | $50,979,000 | $50,537,000 |
| Total Curr. Assets | $1,201,349,000 | $1,194,730,000 | $1,049,954,000 | $923,354,000 |
| Property Plant & Equip (Net) | $328,921,000 | $293,742,000 | $286,459,000 | $269,044,000 |
| Goodwill | $415,207,000 | $418,694,000 | $328,411,000 | $303,030,000 |
| Intangibles | $1,123,714,000 | $1,453,824,000 | $562,496,000 | $623,431,000 |
| Long-Term Investments | $172,239,000 | $144,421,000 | $90,791,000 | $141,206,000 |
| Tax Assets | $98,113,000 | $0 | $84,169,000 | $72,331,000 |
| Other NC Assets | $1,000 | $64,192,000 | $54,238,000 | -$1,000 |
| Total NC Assets | $2,138,195,000 | $2,374,873,000 | $1,406,564,000 | $1,409,041,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,339,544,000 | $3,569,603,000 | $2,456,518,000 | $2,332,395,000 |
| Liabilities | – | – | – | – |
| Payables | $187,840,000 | $185,193,000 | $140,236,000 | $130,739,000 |
| Short-Term Debt | $266,533,000 | $487,222,000 | $88,546,000 | $157,730,000 |
| Tax Payable | $34,549,000 | $38,515,000 | $5,137,000 | $32,388,000 |
| Deferred Revenue | $0 | $0 | -$88,546,000 | -$157,730,000 |
| Other Curr. Liab. | $572,688,000 | $574,795,000 | $580,661,000 | $524,284,000 |
| Total Curr. Liab. | $1,061,610,000 | $1,285,725,000 | $726,034,000 | $687,411,000 |
| LT Debt | $564,893,000 | $518,494,000 | $111,461,000 | $55,690,000 |
| Deferred Rev, NC | $0 | $70,756,000 | $121,279,000 | $138,943,000 |
| Deferred Tax Liab, NC | $5,353,000 | $51,346,000 | $6,048,000 | $5,823,000 |
| Other NC Liab. | $194,433,000 | $96,442,000 | $51,251,000 | $45,733,000 |
| Total NC Liab. | $764,679,000 | $687,890,000 | $222,530,000 | $184,676,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $85,700,000 | $75,007,000 | $72,744,000 |
| Total Liabilities | $1,826,289,000 | $1,973,615,000 | $948,564,000 | $872,087,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $103,001,000 | $103,001,000 | $103,001,000 | $103,001,000 |
| Retained Earnings | $740,939,000 | $809,400,000 | $908,158,000 | $944,261,000 |
| AOCI | $521,580,000 | $533,300,000 | $340,639,000 | $247,512,000 |
| Other Equity | $147,735,000 | $150,287,000 | $156,157,000 | $165,533,000 |
| Total Equity | $1,513,255,000 | $1,595,988,000 | $1,507,954,000 | $1,460,308,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,339,544,000 | $3,569,603,000 | $2,456,518,000 | $2,332,395,000 |
| Net Debt | $643,054,000 | $670,029,000 | -$176,833,000 | -$102,566,000 |